Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2016 2
2017 1
2019 1
2020 1
2021 3
2022 4
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism.
Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N, Gibbs JS, Huisman MV, Humbert M, Kucher N, Lang I, Lankeit M, Lekakis J, Maack C, Mayer E, Meneveau N, Perrier A, Pruszczyk P, Rasmussen LH, Schindler TH, Svitil P, Vonk Noordegraaf A, Zamorano JL, Zompatori M; Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Konstantinides SV, et al. Eur Heart J. 2014 Nov 14;35(43):3033-69, 3069a-3069k. doi: 10.1093/eurheartj/ehu283. Epub 2014 Aug 29. Eur Heart J. 2014. PMID: 25173341 Free article. No abstract available.
Reduced-Dose Intravenous Thrombolysis for Acute Intermediate-High-risk Pulmonary Embolism: Rationale and Design of the Pulmonary Embolism International THrOmbolysis (PEITHO)-3 trial.
Sanchez O, Charles-Nelson A, Ageno W, Barco S, Binder H, Chatellier G, Duerschmied D, Empen K, Ferreira M, Girard P, Huisman MV, Jiménez D, Katsahian S, Kozak M, Lankeit M, Meneveau N, Pruszczyk P, Petris A, Righini M, Rosenkranz S, Schellong S, Stefanovic B, Verhamme P, de Wit K, Vicaut E, Zirlik A, Konstantinides SV, Meyer G; PEITHO-3 Investigators. Sanchez O, et al. Among authors: petris a. Thromb Haemost. 2022 May;122(5):857-866. doi: 10.1055/a-1653-4699. Epub 2021 Oct 31. Thromb Haemost. 2022. PMID: 34560806 Free PMC article. Clinical Trial.
The Pulmonary Embolism International THrOmbolysis (PEITHO)-3 study (ClinicalTrials.gov Identifier: NCT04430569) is a randomized, placebo-controlled, double-blind, multicenter, multinational trial with long-term follow-up. We will compare the efficacy and safety of a reduce …
The Pulmonary Embolism International THrOmbolysis (PEITHO)-3 study (ClinicalTrials.gov Identifier: NCT04430569) is a randomized, placebo-con …
A Real Pandora's Box in Pandemic Times: A Narrative Review on the Acute Cardiac Injury Due to COVID-19.
Timpau AS, Miftode RS, Leca D, Timpau R, Miftode IL, Petris AO, Costache II, Mitu O, Nicolae A, Oancea A, Jigoranu A, Tuchilus CG, Miftode EG. Timpau AS, et al. Among authors: petris ao. Life (Basel). 2022 Jul 20;12(7):1085. doi: 10.3390/life12071085. Life (Basel). 2022. PMID: 35888173 Free PMC article. Review.
We also explore some novel therapeutic strategies involving immunomodulatory therapy, as well as their role in preventing a severe form of the disease, with both the short-term outcome and the long-term cardiovascular sequelae being equally important in patients wit …
We also explore some novel therapeutic strategies involving immunomodulatory therapy, as well as their role in preventing a severe form of t …
Anticoagulation in Acute Coronary Syndrome: Review of Major Therapeutic Advances.
Pop C, Matei C, Petris A. Pop C, et al. Among authors: petris a. Am J Ther. 2019 Mar/Apr;26(2):e184-e197. doi: 10.1097/MJT.0000000000000913. Am J Ther. 2019. PMID: 30839367 Review.
Thus, the overall benefit of adding NOAC to antiplatelet treatment after ACS in patients without clear indication for long-term OAC is still unknown. CONCLUSIONS: Different OACs have been tested as antithrombotic therapy after ACS in combination with single or DAPT and led …
Thus, the overall benefit of adding NOAC to antiplatelet treatment after ACS in patients without clear indication for long-term OAC i …
Recovery of right ventricular function after intermediate-risk pulmonary embolism: results from the multicentre Pulmonary Embolism International Trial (PEITHO)-2.
Mavromanoli AC, Barco S, Ageno W, Bouvaist H, Brodmann M, Cuccia C, Couturaud F, Dellas C, Dimopoulos K, Duerschmied D, Empen K, Faggiano P, Ferrari E, Galiè N, Galvani M, Ghuysen A, Giannakoulas G, Huisman MV, Jiménez D, Kozak M, Lang IM, Meneveau N, Münzel T, Palazzini M, Petris AO, Piovaccari G, Salvi A, Schellong S, Schmidt KH, Verschuren F, Schmidtmann I, Toenges G, Klok FA, Konstantinides SV; PEITHO-2 Investigators. Mavromanoli AC, et al. Among authors: petris ao. Clin Res Cardiol. 2023 Oct;112(10):1372-1381. doi: 10.1007/s00392-022-02138-4. Epub 2022 Dec 21. Clin Res Cardiol. 2023. PMID: 36539534 Free PMC article. Clinical Trial.
Almost one in four patients, however, continued to have evidence of RV dysfunction over the long term....
Almost one in four patients, however, continued to have evidence of RV dysfunction over the long term....
The Effect of Vitamin Supplementation on Subclinical Atherosclerosis in Patients without Manifest Cardiovascular Diseases: Never-ending Hope or Underestimated Effect?
Mitu O, Cirneala IA, Lupsan AI, Iurciuc M, Mitu I, Dimitriu DC, Costache AD, Petris AO, Costache II. Mitu O, et al. Among authors: petris ao. Molecules. 2020 Apr 9;25(7):1717. doi: 10.3390/molecules25071717. Molecules. 2020. PMID: 32283588 Free PMC article. Review.
Though the fundamental premise was optimistic, the up-to-date trials with vitamin supplementation revealed divergent results on subclinical atherosclerosis improvement, both in healthy subjects and patients with CVD, while the long-term effect seems minimal. Thus, there ar …
Though the fundamental premise was optimistic, the up-to-date trials with vitamin supplementation revealed divergent results on subclinical …
An Overview of the Impact of Bacterial Infections and the Associated Mortality Predictors in Patients with COVID-19 Admitted to a Tertiary Center from Eastern Europe.
Timpau AS, Miftode RS, Costache II, Petris AO, Miftode IL, Gheorghe L, Timpau R, Miftode ID, Prepeliuc CS, Coman I, Anton-Paduraru DT, Tuchilus C, Miftode EG. Timpau AS, et al. Among authors: petris ao. Antibiotics (Basel). 2023 Jan 11;12(1):144. doi: 10.3390/antibiotics12010144. Antibiotics (Basel). 2023. PMID: 36671345 Free PMC article.
Secondly, the study aimed to identify the risk factors associated with in-hospital death and evaluate the biomarkers' performance for predicting short-term mortality. 3. RESULTS: Bacterial co-infections or secondary infections were confirmed in 23 (8.2%) patients. ...
Secondly, the study aimed to identify the risk factors associated with in-hospital death and evaluate the biomarkers' performance for predic …
Optimal Teaching of Cardiopulmonary Resuscitation in Schools: Better Education, More Lives Saved.
Petriş AO, Cimpoeşu D, Pop C, Tatu-Chiţoiu G. Petriş AO, et al. Rev Med Chir Soc Med Nat Iasi. 2016 Jul-Sep;120(3):522-9. Rev Med Chir Soc Med Nat Iasi. 2016. PMID: 30044584
Teachers seem to be the best candidates for the instructor position, taking into account the knowledge and skills they acquired throughout the teacher training programs, as well as, their continuous contact with the students; consequently, training teachers to become CPR instruct …
Teachers seem to be the best candidates for the instructor position, taking into account the knowledge and skills they acquired throughout t …
The ESC-EORP Chronic Ischaemic Cardiovascular Disease Long Term (CICD LT) registry.
Komajda M, Cosentino F, Ferrari R, Laroche C, Maggioni A, Steg PG, Tavazzi L, Kerneis M, Valgimigli M, Gale CP; CICD Investigators Group. Komajda M, et al. Eur Heart J Qual Care Clin Outcomes. 2021 Jan 25;7(1):28-33. doi: 10.1093/ehjqcco/qcz057. Eur Heart J Qual Care Clin Outcomes. 2021. PMID: 31605146
AIMS: The European Society of Cardiology (ESC) EURObservational Research Programme (EORP) Chronic Ischaemic Cardiovascular Disease Long Term (CICD LT) registry aims to study the clinical profile, treatment modalities, and outcomes of patients diagnosed with CICD in a conte …
AIMS: The European Society of Cardiology (ESC) EURObservational Research Programme (EORP) Chronic Ischaemic Cardiovascular Disease Long T …
Impact of chronic coronary syndromes on cardiovascular hospitalization and mortality: the ESC-EORP CICD-LT registry.
Kerneis M, Cosentino F, Ferrari R, Georges JL, Kosmachova E, Laroche C, Maggioni AP, Rittger H, Steg PG, Maczynska J, Tavazzi L, Valgimigli M, Gale CP, Komajda M; CICD investigators group. Kerneis M, et al. Eur J Prev Cardiol. 2022 Nov 8;29(15):1945-1954. doi: 10.1093/eurjpc/zwac089. Eur J Prev Cardiol. 2022. PMID: 35653582 Free article.
The European Society of Cardiology (ESC) EURObservational Research Programme (EORP) Chronic Ischemic Cardiovascular Disease Long-Term (CICD-LT) registry is a prospective European registry, and was designed to describe the profile, management, and outcomes of patients with …
The European Society of Cardiology (ESC) EURObservational Research Programme (EORP) Chronic Ischemic Cardiovascular Disease Long-Term …
13 results